期刊文献+

21例多发性骨髓瘤分子遗传学异常的FISH检测的意义 被引量:2

Detection of molecular cytogenetic abnormalities in 21 patients with multiple myeloma by fluorescence in situ hybridization
原文传递
导出
摘要 目的:为探讨间期荧光原位杂交(FISH)在检测多发性骨髓瘤(MM)间期细胞13q14缺失、1q21、p53缺失以及免疫球蛋白重链(IgH)基因重排中的意义。方法:采用组合探针(1q21/RB1、D13S319/p53、IgH)对21例MM患者骨髓进行FISH检测,分析其分子遗传学异常,比较其与常规染色体检查及临床指标的相关性。结果:21例MM患者中,19例(90.48%)检测出1种或1种以上的细胞遗传学异常,15例(71.43%)同时检测出2种及以上的异常。其异常比例从高到低分别为:+1异常(66.67%),IgH基因重排(57.14%),13号染色体缺失(47.62%)和p53基因丢失(23.81%)。3例(14.29%)通过G-显带常规染色体检查发现异常,与FISH比较两者差异有统计学意义(P<0.01)。结论:+1、IgH基因重排及13q14缺失在MM中的发生率较高。FISH技术能提高MM分子遗传学异常的敏感性。 Objective:To investigate the molecular cytogenetic abnormalities in multiple myeloma(MM) by fluorescence in situ hybridization(FISH).Method:Twenty-one patients of MM were enrolled in this study.Panel probes of 1q21/RB1、D13S319/p53 and IgH were used to detect the 13q14 deletion,trisomy 1,p53 deletion and IgH gene rearrangements in these patients as well as conventional chromosome karyotype.Result:19 of 21 patients(90.48%) were detected to have at least one kind of molecular cytogenetic abnormalities by FISH.15 patients(71.43%) were detected to have at least more than two kinds of molecular cytogenetic abnormalities.The incidence of molecular cytogenetic abnormalities from high to low was as followed:trisomy 1(66.67%),IgH gene rearrangements(57.14%),13q14 deletion(47.62%) and p53 deletion(23.81%).3 patients(14.29%) were detected to have conventional chromosome abnormalities.The incidence of conventional chromosome abnormalities was significantly lower than that in FISH(P0.01).Conclusion:The incidence of trisomy 1,IgH gene rearrangements and 13q14 deletion was higher in MM.FISH can increase the detection sensitivity of molecular cytogenetic abnormalities in MM.
出处 《临床血液学杂志(输血与检验)》 CAS 2011年第2期193-195,共3页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 多发性骨髓瘤 间期荧光原位杂交 分子遗传学 multiple myeloma FISH molecular cytogenetic abnormalities
  • 相关文献

参考文献14

  • 1WALKER B A,LEONE P E, CHIECCHIO L, et al. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value [J]. Blood, 2010,116:e56-- 65. 被引量:1
  • 2TRCICR L,SKELIN I K, SUSTERCICD, et al. Cytoge netics of multiple myeloma[J]. Coil Antropol, 2010,34 : 41--44. 被引量:1
  • 3CHEN L J,LI J Y, XU W, et al. Molecular cytogenetic abnormalities in patients with multiple myeloma studied by interphase fluorescence in situ hybridization[J]. Exp 0ncol,2007,29 :116-- 120. 被引量:1
  • 4张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 5FONSECA R,BARLOGIE B, BATAILLE R, et al. Genetics and cytogenetics of multiple myeloma..a work shop report[J]. Cancer Res, 2004,64:1546 -- 1558. 被引量:1
  • 6LIEBISCH P, DOEHNER H. Cytogenetics and molecular cytogenetics in multiple myeloma[J]. Eur J Cancer, 2006, 42:1520--1529. 被引量:1
  • 7NOVAK U, OPPLIGER LEIBUNDGUT E, HAGER J, et al. A high-resolution allelotype of B-cell chronic lym- phocytic leukemia (B-CLL) [J]. Blood, 2002, 100:1787 --1794. 被引量:1
  • 8DEBES-MANLN C S, DEWALD G W, BRYANT S, et al. Chromosome abnormalities clustering and its implica- tions for pathogenesis and prognosis in myeloma[J]. Leukemia, 2003,17:427--436. 被引量:1
  • 9FONSECA R,BAILEY R J, AHMANN G J, et al. Genomic abnormalities in monoclonal gammopathy of unde- termined significance[J]. Blood, 2002,100:1417 -- 1424. 被引量:1
  • 10SHAUGHNESSY J, JACOBSON J, SAWYER J, et al. Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodip- loidy, ensures long-term survival in multiple myeloma treated with Total Therapy I:interpretation in the context of global gene expression[J]. Blood, 2003,101:3849 -- 3856. 被引量:1

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部